We are very proud to present our 2023 Special Issue dedicate to a holistic view of cancer! With 10 Reviews, a Perspective, and our Editorial, we lay out what we see as the future for impactful cancer research. You can read it now:
Online Now: KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
Online Now: Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden